Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 28379587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver injury from herbal and dietary supplements

  2017cited by this paper
• Drug-induced steatohepatitis

  2017cited by this paper
• Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data

  2016cited by this paper
• Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review

  2016cited by this paper
• Malignant biliary obstruction: From palliation to treatment.

  2016cited by this paper
• Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.

  2016cited by this paper
• Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis.

  2016cited by this paper
• Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.

  2016cited by this paper
• Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports

  2016cited by this paper
• Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease

  2016cited by this paper
• Artificial liver support: a real step forward.

  2015cited by this paper
• The value of serum aspartate aminotransferase and gamma‐glutamyl transpetidase as biomarkers in hepatotoxicity

  2015cited by this paper
• Cholestatic liver (dys)function during sepsis and other critical illnesses

  2015cited by this paper
• How to Diagnose and Exclude Drug-Induced Liver Injury

  2015cited by this paper
• Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis.

  2015cited by this paper
• Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury

  2015cited by this paper
• Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury

  2015cited by this paper
• Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

  2015cited by this paper
• Chronic liver injury induced by drugs: a systematic review

  2015cited by this paper
• Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

  2014cited by this paper
• Outbreak of Severe Hepatitis Linked to Weight-Loss Supplement OxyELITE Pro

  2014cited by this paper
• ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

  2014cited by this paper
• Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

  2014cited by this paper
• Drug-Induced Nodular Regenerative Hyperplasia

  2014cited by this paper
• Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network

  2014cited by this paper
• Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

  2014cited by this paper
• Drug-induced liver injury.

  2014cited by this paper
• Drug-Induced Hepatic Steatosis

  2014cited by this paper
• Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis

  2014cited by this paper
• Review article: herbal hepatotoxicity – an update on traditional Chinese medicine preparations

  2014cited by this paper
• Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations

  2013cited by this paper
• Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.

  2013cited by this paper
• Review article: prescribing medications in patients with cirrhosis – a practical guide

  2013cited by this paper
• Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

  2013cited by this paper
• HLA-B*5701 and flucloxacillin associated drug-induced liver disease.

  2013cited by this paper
• Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database.

  2012cited by this paper
• Development of an accurate index for predicting outcomes of patients with acute liver failure.

  2012cited by this paper
• A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea

  2012cited by this paper
• EASL Clinical Practice Guidelines: Wilson's disease.

  2012cited by this paper
• A case of acute valproic acid poisoning treated successfully with L-carnitine.

  2012cited by this paper
• Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: Early discrimination between survival and death

  2012cited by this paper
• Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end‐stage liver disease score for the prognosis of acetaminophen‐induced acute liver failure

  2012cited by this paper
• Case Definition and Phenotype Standardization in Drug‐Induced Liver Injury

  2011cited by this paper
• Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis

  2010cited by this paper
• Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.

  2010cited by this paper
• Risk factors for idiosyncratic drug-induced liver injury.

  2010cited by this paper
• Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity

  2010cited by this paper
• Causality assessment in drug‐induced liver injury using a structured expert opinion process: Comparison to the Roussel‐Uclaf causality assessment method

  2010cited by this paper
• Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.

  2009cited by this paper
• HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

  2009cited by this paper
• Phenotypic characterization of idiosyncratic drug‐induced liver injury: The influence of age and sex

  2009cited by this paper
• Rechallenge in drug-induced liver injury: the attractive hazard

  2009cited by this paper
• Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.

  2009cited by this paper
• Drug-Induced Liver Injury Network (DILIN) Prospective Study

  2009cited by this paper
• Herbal toxicity.

  2009cited by this paper
• United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity

  2008cited by this paper
• Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injury

  2008cited by this paper
• Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

  2008cited by this paper
• Carnitine as an antidote for acute valproate toxicity in children

  2007cited by this paper
• Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?

  2007cited by this paper
• Hepatotoxicity associated with herbal products.

  2006cited by this paper
• Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic

  2006cited by this paper
• Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).

  2006cited by this paper
• Drug-related hepatotoxicity.

  2006cited by this paper
• AASLD position paper: The management of acute liver failure

  2005cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• Incidence of drug-induced liver injury in medical inpatients

  2005cited by this paper
• Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

  2005cited by this paper
• Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden

  2005cited by this paper
• Pathology of peliosis.

  2005cited by this paper
• Acute liver failure

  2005cited by this paper
• Liver transplantation for acute liver failure from drug induced liver injury in the United States

  2004cited by this paper
• Acute and clinically relevant drug-induced liver injury: a population based case-control study.

  2004cited by this paper
• Acute Liver Failure in the United States

  2003cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Incidence of drug‐induced hepatic injuries: A French population‐based study

  2002cited by this paper
• Comparison of two clinical scales for causality assessment in hepatotoxicity

  2001cited by this paper
• Rapid improvement of icterus and pruritus by the oral administration of colestimide in two cases of drug-induced hepatitis.

  2001cited by this paper
• Fulminant exacerbation of autoimmune hepatitis after the use of ma huang

  2001cited by this paper
• Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.

  1999cited by this paper
• Primary biliary cirrhosis

  1998cited by this paper
• Herbs as medicines.

  1998cited by this paper
• Development and validation of a clinical scale for the diagnosis of drug‐induced hepatitis

  1997cited by this paper
• Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink.

  1997cited by this paper
• Fulminant hepatic failure: Summary of a workshop

  1995cited by this paper
• Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications.

  1995cited by this paper
• Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

  1993cited by this paper
• Fatal hepatitis after herbal tea.

  1992cited by this paper
• Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity

  1992cited by this paper
• Criteria of drug-induced liver disorders. Report of an international consensus meeting.

  1990cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Drug-induced liver disease.

  1989cited by this paper
• Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment.

  1981cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper

• Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial

  2025cites this paper
• Construction of naphthalimide-based near-infrared hemicyanine fluorophore and its application for in vivo bioimaging

  2025cites this paper
• The effectiveness of hepatotropic complex Lesil in prevention hepatotoxic effects of anti-helicobacter therapy

  2023cites this paper
• European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline

  2022cites this paper
• Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis

  2022cites this paper
• Drug-Induced Hepatitis in Children: The Experience of a Single Center in Romania

  2022cites this paper
• Prospects of Probiotic Adjuvant Drugs in Clinical Treatment

  2022cites this paper
• European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline.

  2022cites this paper
• Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness.

  2021cites this paper
• Fluoxetine-induced liver injury and skin reaction: A case report

  2021cites this paper
• Effect of acute and chronic liver diseases on the thyroid function in children

  2021cites this paper
• A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection

  2021cites this paper
• Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes

  2021influential citation
• Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities

  2021cites this paper
• Hypolipidemic Therapy in Patients with Chronic Liver Diseases: What Should a Gastroenterologist Know

  2021cites this paper
• Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

  2020cites this paper
• Moderate Hypothermia Effectively Alleviates Acetaminophen-Induced Liver Injury With Prolonged Action Beyond Cooling

  2020cites this paper
• Risk factors associated with the progression of COVID-19 in elderly diabetes patients

  2020cites this paper
• No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19

  2020cites this paper
• Comparison of Lipid Pro fi le, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy

  2020cites this paper
• Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy

  2020cites this paper
• Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

  2020cites this paper
• In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

  2020cites this paper
• Corticosteroid therapy in drug‐induced liver injury: Pros and cons

  2019cites this paper
• Chronic Liver Disease Questionnaire in Duhok City / Kurdistan Region of Iraq

  2019cites this paper
• Evaluation of Efficacy and Safety of “ Test Drug ” in Liver Disorder Subjects with Abnormal Liver Function Test ( LFT )-An Open Labeled , Multicenter , Non-Comparative , Interventional , Prospective Clinical Study

  2019cites this paper
• Epidemiological differences of common liver conditions between Asia and the West

  2019cites this paper
• Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature

  2019cites this paper
• Acute HEV hepatitis: clinical and laboratory diagnosis.

  2019cites this paper
• Drug Induced Liver Injury (DILI) Secondary to Homeopathic Drug (Chelidonium Majus) and Literature Review

  2019cites this paper
• Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

  2019cites this paper
• Diagnostic performance of transient elastography for staging of liver fibrosis of patients with drug-induced liver injury

  2019cites this paper
• [The problem of safety of lipid-lowering therapy].

  2019cites this paper
• A liver transplant recipient with possible bupivacaine-induced liver injury caused by intra-articular injection after total knee arthroplasty

  2018cites this paper
• Fatigue in chronic liver disease: New insights and therapeutic approaches

  2018cites this paper
• Hy’s Law and eDISH for Clinical Studies

  2018cites this paper
• Editorial - Drug-induced hepatotoxicity.

  2017cites this paper
• Comparison of Lipid Pro fi le, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy

  year unknowncites this paper